QIAGEN Aktie
38,67EUR | 0,10EUR | 0,25% |
WKN DE: A400D5 / ISIN: NL0015001WM6
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,72 |
Massachusetts Financial Services Co. | 10,85 |
Massachusetts Financial Services Co. | 10,42 |
Wellington Management Co. LLP | 9,58 |
Wellington Management Co. LLP (Wellington Breakout) | 5,80 |
Norges Bank Investment Management | 2,94 |
Wellington Management International Ltd. | 2,94 |
Government Pension Fund - Global (The) | 2,87 |
Vanguard Group, Inc. (Subfiler) | 2,74 |
Amundi Asset Management | 2,55 |
UBS Asset Management (Americas) LLC | 2,04 |
Nuance Investments LLC | 2,03 |
MFS International Equity Fund - US | 2,00 |
Pendal Group Ltd. | 1,94 |
Norges Bank (13F) | 1,89 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 5 096 | 5 610 | 6 028 | 6 178 | 5 967 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,30 | 0,33 | 0,37 | 0,35 | 0,33 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 570 | 1 667 | 2 110 | 2 394 | 2 148 |
Summe Anlagevermögen | 3 665 | 4 245 | 4 037 | 3 894 | 3 968 |
Summe Aktiva | 5 236 | 5 913 | 6 147 | 6 288 | 6 115 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 1 765 | 2 032 | 2 040 | 1 955 | 1 611 |
Summe Fremdkapital | 2 699 | 3 115 | 3 050 | 2 821 | 2 307 |
Summe Eigenkapital | 2 537 | 2 798 | 3 097 | 3 467 | 3 808 |
Summe Passiva | 5 236 | 5 913 | 6 147 | 6 288 | 6 115 |
Adresse
Hulsterweg 82, 5912 PL Venlo | |
Telefon | +31 (77) 355-66-00 |
Internet | http://www.qiagen.com |
Management
Antonio Santos
Senior Vice President & Head-Global Operations |
Bert van Meurs
Member-Supervisory Board |
Elaine R. Mardis
Member-Supervisory Board |
Elizabeth E. Tallett
Member-Supervisory Board |
Eva Pisa
Member-Supervisory Board |
Eva van Pelt
Member-Supervisory Board |
Jean-Pascal Viola
SVP, Head-Strategy & Business Development |
John Gilardi
Head-Investor Relations & Corporate Communications |
Jonathan G. Sheldon
Senior VP-Digital Insights Business Area |
Lawrence A. Rosen
Chairman-Supervisory Board |
Lezette Young
Manager-Global Compliance |
Metin Colpan
Member-Supervisory Board |
Nedal Safwat
VP & Head-Molecular Diagnostics North America |
Philipp von Hugo
VP, Head-Global Legal Affairs & Compliance |
Roland Sackers
Chief Financial Officer & Managing Director |
Ross L. Levine
Member-Supervisory Board |
Stephany Foster
Senior Vice President & Head-Human Resources |
Stephen H. Rusckowski
Member-Supervisory Board |
Thierry Bernard
Chief Executive Officer & Managing Director |
Thomas Theuringer
Senior Director-Corporate Communications |
Toralf Haag
Member-Supervisory Board |